Expert Highlights Evolution of Biosimilars in Oncology
Pharma & biotech2018-06-29
25 Views
Michael Savin, MD, discusses the emergence of biosimilars in oncology, and why there are still obstacles with incorporating them into clinical practice.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
The Best Web Architectures for Your Business App
CompTIA Security+: Vendor-Neutral Badge with Limitless Opportunities. How to Earn It with Practice Tests?
